We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Enhanced Platform Processes IHC and ISH Patient Samples

By LabMedica International staff writers
Posted on 11 Aug 2011
An enhanced platform enables laboratories to process individual immunohistochemistry (IHC) and in situ hybridization (ISH) samples as soon as they arrive in the lab.

The improvement allows labs to respond quickly to unpredictable changes in workflow, improving test turnaround time and reducing stress associated with day-to-day laboratory changes. More...


The BenchMark ULTRA with new Ultimate Reagent Access (URA) provides a new software and hardware package which gives the operator full workflow control by allowing access to any slide, any reagent, anytime. URA eliminates the need to batch slides, reduces preplanning requirements, and allows late-arriving slides to be run STAT.

URA completes the total system access of ULTRA, increasing overall slide turnaround time because instrument preparation tasks can be managed while slides are processing. Multiparameter testing, such as dual and triple stains, can be performed independent of other slides, allowing for rapid patient results. With URA, labs can manage workflow with random access to 30 individual staining chambers, allowing for real-time STAT processing.

The new BenchMark ULTRA platform together with URA was launched by Ventana Medical Systems, Inc. (Tucson, AZ, USA), a member of the Roche Group (Basel, Switzerland).

Related Links:
Ventana Medical Systems
Roche


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.